A randomised trial of six versus twelve courses of chemotherapy in metastatic carcinoma of the breast
- 1 November 1997
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 33 (13) , 2194-2197
- https://doi.org/10.1016/s0959-8049(97)00396-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 monthsEuropean Journal Of Cancer, 1993
- Continuous chemotherapy in responsive metastatic breast cancer: a role for tumour markers?British Journal of Cancer, 1993
- Interrupted versus Continuous Chemotherapy in Patients with Metastatic Breast CancerNew England Journal of Medicine, 1991
- Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancerThe Lancet, 1990
- Improving the Quality of Life during Chemotherapy for Advanced Breast CancerNew England Journal of Medicine, 1987
- FAILURE OF CHEMOTHERAPY TO PROLONG SURVIVAL IN A GROUP OF PATIENTS WITH METASTATIC BREAST CANCERThe Lancet, 1980
- Assessment of response to therapy in advanced breast cancerBritish Journal of Cancer, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Combination chemotherapy for metastatic breast carcinoma.Prospective comparison of multiple drug therapy with L-phenylalanine mustardCancer, 1976
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958